Fatal systemic candidiasis following treatment of Addisonian crisis in a juvenile diabetic.
D000224:Addison Disease / Q000150:complications*; D000293:Adolescent; D000818:Animals; D000900:Anti-Bacterial Agents / Q000009:adverse effects; D001327:Autoimmune Diseases; D001786:Blood Glucose; D001922:Brain Abscess / Q000150:complications; D002177:Candidiasis / Q000209:etiology*; D002404:Catheterization; D003907:Dexamethasone / Q000627:therapeutic use; D003922:Diabetes Mellitus, Type 1 / Q000150:complications*; D005938:Glucocorticoids / Q000009:adverse effects; D006335:Heart Injuries / Q000150:complications; D006801:Humans; D006965:Hyperplasia / Q000150:complications; D007166:Immunosuppressive Agents / Q000009:adverse effects; D066298:In Vitro Techniques; D007330:Insulin Antibodies; D007410:Intestinal Diseases / Q000139:chemically induced; D007515:Islets of Langerhans / Q000503:physiopathology; D008214:Lymphocytes; D008297:Male; D008590:Meningoencephalitis / Q000150:complications; D010672:Phenytoin / Q000627:therapeutic use; D051381:Rats; D013552:Swine; D014081:Tooth Extraction / Q000009:adverse effects*
D000900:Anti-Bacterial Agents; D001786:Blood Glucose; D005938:Glucocorticoids; D007166:Immunosuppressive Agents; D007330:Insulin Antibodies; D010672:Phenytoin; D003907:Dexamethasone